Opthea Ltd (OPTEY) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
OPTEY Profit Margin, ROE & Profitability Analysis
OPTEY vs Healthcare Sector: How Opthea Ltd Compares
How Opthea Ltd compares to Healthcare sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Opthea Ltd Stock Overvalued? OPTEY Valuation Analysis 2026
Based on fundamental analysis, Opthea Ltd has mixed fundamental signals relative to the Healthcare sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Opthea Ltd Balance Sheet: OPTEY Debt, Cash & Liquidity
OPTEY Revenue Growth, EPS Growth & YoY Performance
OPTEY SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Opthea Ltd (CIK: 0001815620)
📋 Recent SEC Filings
❓ Frequently Asked Questions about OPTEY
What is the AI rating for OPTEY?
Opthea Ltd (OPTEY) has an AI grade of N/A with 0% confidence, based on fundamental analysis of SEC EDGAR filings.
What are OPTEY's key strengths?
Claude: Analysis in progress.
What are the risks of investing in OPTEY?
Claude: Analysis in progress.
What is OPTEY's revenue and growth?
Opthea Ltd reported revenue of N/A.
Does OPTEY pay dividends?
Opthea Ltd does not currently pay dividends.
Where can I find OPTEY SEC filings?
Official SEC filings for Opthea Ltd (CIK: 0001815620) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is OPTEY's EPS?
Opthea Ltd has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is OPTEY's fundamental grade?
Based on our AI fundamental analysis in July 2026, Opthea Ltd has a N/A grade with 0% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is OPTEY stock overvalued or undervalued?
Valuation metrics for OPTEY: ROE of N/A (sector avg: 15%), net margin of N/A (sector avg: 12%). Compare these metrics with sector averages to assess valuation.
What is OPTEY's AI grade for 2026?
Our dual AI analysis gives Opthea Ltd a combined N/A grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is OPTEY's free cash flow?
Opthea Ltd's operating cash flow is N/A, with capital expenditures of N/A.
How does OPTEY compare to other Healthcare stocks?
Vs Healthcare sector averages: Net margin N/A (avg: 12%), ROE N/A (avg: 15%), current ratio N/A (avg: 2).